Dr Marco Penske has been the Head of Market Access and Healthcare Affairs of Boehringer Ingelheim since 2011.
Dr Marco Penske has studied Economics at the University of Mainz with focus on Health Economics and Statistics. Afterwards, he was working as a Research Assistant at the chair of Finance and Economics at the same university. After his promotion about questions of financing healthcare systems and the expansion of capital covered elements, he was employed at a business consultancy company. In 2007 he has joined Boehringer Ingelheim. His current responsibilities are among others the benefit assessment and price negotiation after AMNOG, the development of pricing strategies and contract models for pharmaceuticals and the healthcare affairs activities. Moreover, he is an active speaker on congresses and working as a lecturer.